Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
Quick Stats
Jan 30, 202656.5
AI Score
HOLD0.36
Volume Ratio
Mar 06, 2026
Next Earnings
12
+ve Days (30d)
17
-ve Days (30d)
KLRS Stock Summary
Last updated Jan 30, 2026
KLRS is currently trading at $8.88, positioned above its 200-day moving average of $5.06, indicating a long-term uptrend. The stock has a 52-week range of $2.14 to $12.9.
Technical Analysis: The 50-day moving average stands at $8.31, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 48.226, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.007, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates KLRS at 56.5/100 with a HOLD recommendation.
KLRS (Kalaris Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 48.226 |
| CMF (20) | -0.007 |
| ROC (10) | 0.226 |
| ADX (14) | 40.11 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.309 |
| AROONOSC (14) | 78.571 |
| WILLAMS %R (14) | -85.252 |
| MFI (14) | 35.747 |
KLRS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
KLRS Price vs Max Options Open Interest
KLRS Max Change In Options Open Interest
KLRS Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KLRS Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KLRS Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KLRS Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Kalaris Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
KLRS Moving Averages Analysis
Kalaris Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Kalaris Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
KLRS (Kalaris Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 9.64 |
| 20 | 9.2 |
| 30 | 9.29 |
| 50 | 8.31 |
| 100 | 6.7 |
| 200 | 5.06 |
KLRS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 172.1 million |
| Earnings/Share ($) | -38.05 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.6967 |
| EPS Estimate Next Year ($) | -2.4817 |
| WallStreet Target Price ($) | 19.6667 |
| Most Recent Quarter |